First Page | Meta Content | |
---|---|---|
Document Date: 2013-10-09 09:36:26Open Document File Size: 104,98 KBShare Result on FacebookCityBerlin / /CompanyBundesverband der Pharmazeutischen Industrie / /CountryUnited States / United Kingdom / India / / /IndustryTermchemical and biological actives / clinical trial protocol / biotechnology / pharmaceutical industry / insurance fees / auxiliary medicinal products / pharmaceutical industry activities / ultra orphan medicinal products / insurance needs / manufacturing / pharmaceutical products / pharmaceutical / insurance/indemnity / health technology assessments / /MedicalConditionfastly-progressing diseases / rare diseases / disease / rare and ultra rare diseases / rare and ultra-rare diseases / diseases / MS / /MedicalTreatmentcomplementary medicine / homeopathy / anthroposophy / /OrganizationBPI / European Commission / German Pharmaceutical Industry Association / Ethical Committee / European Union / / /Positioninvestigator / General / legal representative / /ProgrammingLanguageEC / /ProvinceOrStateMississippi / California / /Technologybiotechnology / clinical trial protocol / /URLwww.bpi.de / /SocialTag |